Abstract

BackgroundLong non-coding RNAs (lncRNAs) have emerged as important regulators of human cancers. However, the functional roles of lncRNAs and the mechanisms responsible for their aberrant expression in gastric cancer (GC) have not been well characterized.MethodsIn this study, we examined the expression of lncRNA UFC1 in GC by qRT-PCR and explored its correlation with clinicopathological parameters. In vitro cell functional assays and in vivo animal studies were performed to determine the roles of UFC1 in GC progression.ResultsUFC1 was elevated and predicted poorer prognosis in GC. UFC1 knockdown inhibited while UFC1 overexpression promoted GC cell proliferation, migration, and invasion. UFC1 bound to miR-498 to antagonize its tumor suppressive effect on Lin28b. Suppression of Lin28b by miR-498 could be rescued by UFC1 overexpression, whereas Lin28b overexpression partially rescued UFC1 knockdown-mediated inhibition of GC cell function. Lin28b expression was increased in GC and suggested a co-expression pattern with UFC1.ConclusionsUFC1 has a promoting role in GC progression, at least in part, by acting as a miR-498 sponge and derepressing Lin28b expression, which would provide a novel biomarker for GC diagnosis and prognosis and offer a potential target for GC therapy.

Highlights

  • Long non-coding RNAs have emerged as important regulators of human cancers

  • We have recently reported that ZNFX1 antisense RNA1 (ZFAS1) is upregulated in gastric cancer and its expression level was associated with GC progression [8]

  • We found that the expression level of exosomal UFC1 was increased in GC patients compared to that in healthy controls (Fig. 1d)

Read more

Summary

Introduction

Long non-coding RNAs (lncRNAs) have emerged as important regulators of human cancers. The functional roles of lncRNAs and the mechanisms responsible for their aberrant expression in gastric cancer (GC) have not been well characterized. Long non-coding RNAs (lncRNAs) have emerged as new players in human health and diseases. GClnc is upregulated and associated with tumor size, metastasis, and poor prognosis in gastric cancer. We have recently reported that ZFAS1 is upregulated in gastric cancer and its expression level was associated with GC progression [8]. These findings suggest that lncRNA is critically involved in the pathogenesis of GC and may be utilized as biomarkers for GC diagnosis and prognosis

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.